Allergic Rhinitis Clinical Trial
Official title:
Home Usability of a Nasal Lavage System in Children
Verified date | July 2010 |
Source | Aardvark Medical Company |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Observational |
This study evaluates labeling comprehension, ease of use and effectiveness of a new device for nasal and sinus irrigation and/or aspiration. The device is currently cleared for professional use and home use with a prescription. This is a usability study to demonstrate that this device is appropriate for home use.
Status | Completed |
Enrollment | 30 |
Est. completion date | August 2009 |
Est. primary completion date | August 2009 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | N/A to 5 Years |
Eligibility |
Inclusion Criteria: - Parents of children less than 6 years of age who were suffering from nasal congestion for which nasal suctioning and salt water irrigation/drops are prescribed. Exclusion Criteria: - Parents of children in marked respiratory distress or who maxillofacial malformations not conducive to nasal suctioning. - Additionally, parents of children with recurrent nose bleeds, bleeding disorders or irritated peri-nasal skin were excluded. |
Observational Model: Case Control, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
United States | Advanced Pediatrics | Vienna | Virginia |
Lead Sponsor | Collaborator |
---|---|
Aardvark Medical Company |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of Participants Who Properly Used the Nasal Irrigator/Aspirator Device | 'Proper use' is defined as successfully completing all of the following five steps: Attaching wash-head to handle properly Positioning child correctly for procedure as per the user manual's instructions Using the device's control button correctly for both irrigation and aspiration Placing the wash-head tip correctly at the nasal opening Using the device for up to but not exceeding five seconds |
Day one, immediately | Yes |
Secondary | Number of Participants Who Experienced Ease of Use With the Device | After using the device, the caregiver answered this question on a five point Likert-like scale with increasing favorability with increasing number. An answer of 3 or greater is considered an affirmative answer. Such responses reported along with the exact 95% confidence intervals. The question and scale are as follows: How easy was the device to use? 1 difficult, 2 somewhat hard, 3 fairly easy, 4 easy, 5 very easy |
Day one, immediately | Yes |
Secondary | Number of Participants Who Found the Device to be Effective | After using the device, the caregiver answered this question on a five point Likert-like scale with increasing favorability with increasing number. The proportion answering 3 or greater is reported along with the exact 95% confidence intervals. The question and scale are as follows: How well did the device remove nasal secretions? 1 difficult, 2 somewhat hard, 3 fairly easy, 4 easy, 5 very easy |
Day one, immediately | No |
Secondary | Number of Participants Who Identified the Device's User Manual as Easy to Understand | After using the device, the caregiver answered this question on a five point Likert-like scale with increasing favorability with increasing number. The proportion answering 3 or greater is reported along with the exact 95% confidence intervals. The question and scale are as follows: How easy was the manual to understand? 1 difficult, 2 somewhat hard, 3 fairly easy, 4 easy, 5 very easy |
Day one, immediately | Yes |
Secondary | Number of Patients Who Were Observed to Have an Adverse Event | While using the device, the patients were observed by the research coordinator for any of the following adverse events to occur: bloody nose being sprayed in the eye with the saline vomiting after the procedure choking during or after the procedure other |
Day one, immediately | Yes |
Secondary | Number of Patients Experiencing a Physical Injury During Use | After the procedure, the patient was directly examined for any of the following: bleeding from the nostrils disruption of the skin around the nose increased work of breathing/respiratory distress (increased respiratory rate, increased respiratory accessory muscle use) |
Day one, immediately | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05080322 -
Efficacy and Safety of On-demand and Continuous Administration of Nasal Spray in the Treatment of Allergic Rhinitis
|
Phase 4 | |
Recruiting |
NCT06028490 -
A Study of IL4Rα Monoclonal Antibody in Patients With Uncontrolled Seasonal Allergic Rhinitis.
|
Phase 2 | |
Completed |
NCT04388358 -
Traditional Chinese Medicine for the Treatment of Perennial Allergic Rhinitis on Gut Microbiota and Immune-modulation
|
N/A | |
Recruiting |
NCT04202263 -
Assessment of Suppression of Cutaneous Allergic Responses and Pruritis by Topical Minocycline
|
Phase 2 | |
Completed |
NCT04078009 -
Standardising Nasal Allergen Challenge in Adult With Hay Fever
|
N/A | |
Completed |
NCT03644680 -
Changes in Adaptive Immune Responses and Effector Cell Responses Upon Nasal Allergen Exposure - a Pilot Study
|
N/A | |
Completed |
NCT04541004 -
Adolescent Mite Allergy Safety Evaluation
|
Phase 3 | |
Recruiting |
NCT05378594 -
HDM and Silver Birch NAC Standardisation
|
N/A | |
Not yet recruiting |
NCT05684380 -
Efficacy and Safety of MAZ-101 in the Treatment of Persistent Allergic Rhinitis (PER)
|
Phase 3 | |
Completed |
NCT02943720 -
ATIBAR - Efficacy and Safety of Two Doses of AllerT in Patients Allergic to Birch Pollen
|
Phase 2 | |
Completed |
NCT02910401 -
Clinical Response to Rhinovirus Challenge
|
Phase 2 | |
Not yet recruiting |
NCT01014325 -
Safety and Efficacy Study With Allergen Extracts of House Dust Mites for Specific Sublingual Immunotherapy
|
Phase 3 | |
Completed |
NCT02556801 -
Efficacy and Safety of SUBLIVAC Phleum for Immunotherapy of Grass Pollen-Allergy
|
Phase 2 | |
Not yet recruiting |
NCT02233426 -
Effect of Hypertonic Solutions on Allergic Rhinitis Patients
|
N/A | |
Completed |
NCT02352168 -
Airway Inflammation in Children With Allergic Rhinitis and Intervention
|
N/A | |
Completed |
NCT01946035 -
Alpha-Blockers in Allergic Rhinitis (MAN 01)
|
Phase 4 | |
Completed |
NCT01918956 -
PURETHAL Birch RUSH Study
|
Phase 4 | |
Completed |
NCT01682070 -
SUBLIVAC FIX Phleum Pratense DT/DRF
|
Phase 2 | |
Recruiting |
NCT01454492 -
The Relationship Between Allergic Rhinitis and Geographic Tongue
|
N/A | |
Completed |
NCT01438463 -
PURETHAL® Mites Dose Range Finding Study in Patients With Persistent Allergic Rhinitis/Rhinoconjunctivitis
|
Phase 2 |